Login / Signup

Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer.

Huan WuRongrong LiZhiwei ZhangHuiyang JiangHanlin MaCunzhong YuanChenggong SunYingwei LiBeihua Kong
Published in: Journal of ovarian research (2020)
The original article [1] contains errors in Fig. 3C, Results and Discussion.
Keyphrases
  • high grade
  • low grade
  • patient safety
  • adverse drug
  • emergency department